ArticleScientific reports2025
Hardware IP protection by exploiting IP vendor's proteogenomic BioMarker as digital watermark during behavioral synthesis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Handling the threats of intellectual property (IP) piracy and false IP ownership claim, are central from the perspective of IP vendor' right as well as reliability of system-on-chip (SoC) designs. IP design piracy has become an emergent concern for the digital hardware design community, in the last few years. This paper presents a novel behavioral synthesis based hardware IP Protection methodology that exploits IP vendor's proteogenomic Bio-marker as digital Watermark (BioW-IPP), for detective countermeasure against IP piracy and quashing false IP ownership claim. The proposed approach is capable of exploiting the IP vendor's bio-watermark (proteogenomic signature) as secret digital evidence (BW-ID) to generate a robust hardware watermark for embedding into the IP design during behavioral synthesis/high level synthesis (HLS) process. The generated proteogenomic signature bio-watermark is embedded into the register allocation phase of behavioral synthesis (HLS) that ensures negligible design overhead post-embedding. The proposed approach on comparison with prior behavioral synthesis based watermarking techniques achieved greater security in terms of lower probability of coincidence (watermark collision) and higher tamper tolerance, at nominal design overhead.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.